or
Looking to list your PhD opportunities? Log in here.
Research output data provided by the Research Excellence Framework (REF)
Click here to see the results for all UK universitiesDr Aneika Leney graduated from the University of York in 2008 with a BSc in Biochemistry, during which she undertook an industrial placement at GlaxoSmithKline that sparked her interest in Mass Spectrometry. She completed her PhD in 2013 at the University of Leeds, where she was supervised by Professors Sheena Radford and Alison Ashcroft at the Astbury Centre, focusing on using mass spectrometry to study protein structure and function. Following her PhD, Dr Leney moved to Canada to join the Alberta Glycomics Centre, where her post-doctoral research involved developing novel methodologies to monitor protein-ligand interactions. She then worked at a leading laboratory at Utrecht University in the Netherlands, conducting significant proteomics research under the supervision of Professor Albert Heck, concentrating on protein post-translational modifications and their effects on protein function. Currently, at the University of Birmingham, Dr Leney leads her own research group that employs advanced mass spectrometry techniques to analyse proteins and protein complexes, addressing biological questions related to protein communication and functionality. Her research also investigates the potential biotechnological applications of protein modifications, including uses in food colouring, protein visualisation, and solar energy harvesting.
Dr Leney''s research focuses on structural biology-based mass spectrometry, specifically on protein post-translational modifications and their role in communication or miscommunication in diseases. She is exploring how protein modifications can be utilised for biotechnological applications, including food colouring, protein visualisation, and harvesting light energy for solar panels. Dr Leney leads a research group that employs state-of-the-art mass spectrometry techniques to analyse proteins and protein complexes, aiming to understand how proteins communicate and switch between active and inactive states. Her research also involves developing novel techniques to analyse protein post-translational modifications and applying these techniques to solve complex biological problems.
Professor Helen J. Cooper obtained her BSc and PhD in Chemistry at the University of Warwick. She began her post-doctoral career at the University of Warwick, before taking a faculty position at the National High Magnetic Field Laboratory, Florida State University, in 2000. In 2003, she returned to the UK as a Wellcome Trust Value-in-People Fellow at the University of Birmingham. She was subsequently awarded a Wellcome Trust University Technology Fellowship to develop high-performance mass spectrometry methods for use in biomedical research. In 2010, she took up the post of Senior Lecturer. Professor Cooper is a world leader in the field of electron capture dissociation mass spectrometry and is responsible for establishing the University of Birmingham as a centre of excellence in mass spectrometry research. She has published extensively in peer-reviewed journals and serves on a number of national and international committees, including the Editorial Board for the Journal of the American Society for Mass Spectrometry and the British Mass Spectrometry Society.
Professor Helen J. Cooper''s research focuses on the gas-phase ion chemistry of peptides and proteins, with a particular expertise in electron capture dissociation mass spectrometry. She has established the University of Birmingham as a centre of excellence in mass spectrometry research. Her current research includes the development and application of advanced mass spectrometry techniques for the analysis of biomolecular and chemical structures. Key areas of focus include the development of methods for proteomics, understanding the fundamentals of peptide fragmentation, analysis of post-translational modifications, and the integration of ion mobility spectrometry with mass spectrometry. Additionally, she is involved in developing mass spectrometry-based methods for diagnosing inherited disorders in newborns in collaboration with Birmingham Children’s Hospital. Professor Cooper has published extensively in peer-reviewed journals and serves on various national and international committees, including the Editorial Board for the Journal of the American Society for Mass Spectrometry and the British Mass Spectrometry Society.